Patents by Inventor Aimee Freeman

Aimee Freeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemically modified novel erythropoietin stimulating protein compositions and methods
    Patent number: 7262166
    Abstract: The present invention broadly relates to the field of protein modification, and, more specifically, the attachment of water soluble polymers to novel erythropoietin stimulating protein (NESP).
    Type: Grant
    Filed: April 7, 2003
    Date of Patent: August 28, 2007
    Assignee: Amgen Inc.
    Inventors: Olaf Kinstler, Colin Gegg, Aimee Freeman, Thomas Boone
  • Chemically modified novel erythropoietin stimulating protein compositions and methods
    Publication number: 20060264377
    Abstract: The present invention broadly relates to the field of protein modification, and, more specifically, the attachment of water soluble polymers to novel erythropoietin stimulating protein (NESP).
    Type: Application
    Filed: August 2, 2006
    Publication date: November 23, 2006
    Inventors: Olaf Kinstler, Colin Gegg, Aimee Freeman, Thomas Boone
  • Chemically modified novel erythropoietin stimulating protein compositions and methods
    Publication number: 20030166566
    Abstract: The present invention broadly relates to the field of protein modification, and, more specifically, the attachment of water soluble polymers to novel erythropoietin stimulating protein (NESP).
    Type: Application
    Filed: April 7, 2003
    Publication date: September 4, 2003
    Applicant: Amgen Inc.
    Inventors: Olaf Kinstler, Colin Gegg, Aimee Freeman, Thomas Boone
  • Chemically modified novel erythropoietin stimulating protein compositions and methods
    Patent number: 6586398
    Abstract: The present invention broadly relates to the field of protein modification, and, more specifically, the attachment of water soluble polymers to novel erythropoietin stimulating protein (NESP).
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: July 1, 2003
    Assignee: Amgen, Inc.
    Inventors: Olaf Kinstler, Colin Gegg, Aimee Freeman, Thomas Boone